MOLE', Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.030
EU - Europa 605
AS - Asia 362
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 3.004
Nazione #
US - Stati Uniti d'America 2.027
CN - Cina 221
UA - Ucraina 154
PL - Polonia 136
DE - Germania 101
TR - Turchia 86
IT - Italia 66
GB - Regno Unito 59
SG - Singapore 49
SE - Svezia 43
FI - Finlandia 35
RU - Federazione Russa 6
BE - Belgio 4
CA - Canada 3
EU - Europa 3
VN - Vietnam 3
ID - Indonesia 2
BR - Brasile 1
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 3.004
Città #
Woodbridge 268
Chandler 205
Fairfield 199
Ashburn 193
Jacksonville 185
Houston 162
Warsaw 136
Ann Arbor 132
Wilmington 85
Seattle 75
Cambridge 65
Addison 52
Nanjing 44
Beijing 42
Izmir 42
Princeton 35
Boardman 32
Singapore 30
Shanghai 26
Dearborn 25
Ferrara 25
Bremen 20
Milan 19
San Diego 17
Shenyang 17
Jinan 15
Mountain View 13
Nanchang 12
New York 10
Washington 10
Tianjin 9
Hebei 8
Jiaxing 8
Auburn Hills 7
Changsha 7
Orange 6
Indiana 5
Norwalk 5
Brussels 4
Cagliari 4
Ningbo 4
Redwood City 4
Tappahannock 4
Augusta 3
Chengdu 3
Dong Ket 3
Falls Church 3
Guangzhou 3
Hefei 3
Kunming 3
Lanzhou 3
Leawood 3
Los Angeles 3
Padova 3
Taizhou 3
Bologna 2
Helsinki 2
Jakarta 2
Kingston 2
London 2
Rome 2
Taiyuan 2
Ardabil 1
Canaro 1
Changchun 1
Des Moines 1
Dongguan 1
Fuzhou 1
Haikou 1
Hangzhou 1
Harbin 1
Kilburn 1
Knoxville 1
Munich 1
Navegantes 1
Nürnberg 1
San Francisco 1
San Mateo 1
Southwark 1
Toronto 1
Tosagua 1
Walnut 1
Totale 2.336
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 164
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 157
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 130
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 124
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 122
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 115
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 114
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 114
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 114
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 113
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 108
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 106
Growth hormone excess promotes breast cancer chemoresistance 105
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 104
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 91
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 80
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 77
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 74
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 73
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 72
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 72
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 72
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 68
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 67
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 67
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 67
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 66
Targeting PKC in human pancreatic neuroendocrine tumor cells 65
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 64
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 57
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 54
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 51
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 49
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  18
Totale 3.034
Categoria #
all - tutte 11.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020649 99 21 23 95 39 86 53 64 47 82 28 12
2020/2021416 39 33 16 74 9 50 10 53 5 51 60 16
2021/2022313 13 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024252 21 22 11 9 16 41 9 77 3 3 2 38
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 3.034